# 



## 



## 



## 

## 

## 

## 

## 



## 

## 

## 



## 

## 

## 



## 

## 

## 

## 



## 

## 



## 

## 



## 

## 

## 




## 

## 



## 

## 



## 

## 


## 



## 



## 



## 

## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 



## 

|||Nate|Unrestricted|Restricted|Total Funds|Unrestricted|Restricted|Total Funds|
|---|---|---|---|---|---|---|---|---|
||||Funds|Funds|Yearfnded|Funds|Funds|Year Ended|
||||f'000|f'000|31March|f'000|f'000|31March|
||||||2023|||2022|
||||||f'000|||f'000|
|Income|||||||||
|Donations and|||2,685|2,772|5,457|2,128|2,264|4,392|
|legacies|||||||||
|Income fram||4|1,680|157|1,837|1,326|90|1,416|
|charitable<br>activities|||||||||
|Income from other|||792||792|722||722|
|trading activities|||||||||
|Investment<br>income||3|198||198|103||103|
|Total income|||5,355|2,929|8,284|4,279|2,354|6,633|
|Expenditure|||||||||
|Cost of raising|||1,873||1,873|1,722||1,722|
|funds|||||||||
|Expenditure<br>on||6|3,667|2,507|6,174|3,749|2,199|5,948|
|charitable<br>activities|||||||||
|Total expenditure|||5,540|2,507|8,047|5,471|2,199|7,670|
|Realised and|||(235)||(235)|252||252|
|unrealised<br>gain/|||||||||
|(loss) an|||||||||
|investments|||||||||
|Net income /|||(420)|422|2|(940)|155|(785)|
|(expenditure)|||||||||
|Net movement|on||(420)|422|2|(940)|155|(785)|
|funds|||||||||
|Total funds|||4,694|3,054|7,748|5,634|2,899|8,533|
|brought forward|||||||||
|Total funds carried|||4,274|3,476|7,750|4,694|3,054|7,748|
|forward|||||||||





## 

## 

|||||Group|Charity|Group|Charity|
|---|---|---|---|---|---|---|---|
||||Note|2023|2023|2022|2022|
|||||f'000|f'000|f'000|f'000|
|Fixed Assets||||||||
|Tangible fixed assets||||38||43||
|Investments||||9,945|9,945|8,852|8,852|
|Total fixed assets||||9,983|9,945|8,895|8,852|
|Current assets||||||||
|Stock|||10|36||36||
|Debtors|||11|942|1,118|621|849|
|Cash at bank|and in|hand|12|1,470|1,296|2,959|2,779|
|Total current|assets|||2,448|2,414|3,616|3,628|
|Liabilities||||||||
|Creditors falling due||within one year|13|(4,681)|(4,609)|(4,763)|(4,732)|
|Net current|assets /|(liabilities)||(2,233)|(2,195)|(1,147)|(1,104)|
|Total assets|less current liabilities|||7,750|7,750|7,748|7,748|
|Creditors: Amounts||falling due after||||||
|more than one year|||23|||||
|Net assets||||7,750|7,750|7,748|7,748|
|Funds||||||||
|Unrestricted|income|funds|14|4,274|4,274|4,694|4,694|
|Restricted income funds|||14|3,476|3,476|3,054|3,054|
|Total funds||||7,750|7,750|7,748|7,748|





## 

||||Note|Year Ended|Year Ended|Year Ended|Year Ended|
|---|---|---|---|---|---|---|---|
|||||31March 2023||31March 2022||
|||||f000|EOOD|EOM|EOM|
|Cash flows from operating activities:||||||||
|Net cash (used in) / provided<br>by operating<br>activities|||||(359)||1,622|
|Cash flows from investing activities:||||||||
|Dividends<br>and interest from investments|||3|198||103||
|Payments to acquire tangible<br>fixed assets|||8|||(20)||
|Payments to acquire investments<br>/ deposits|||9|(3,233)||(1,454)||
|Receipts from sales ofinvestments/ withdrawals|||9|1,905||682||
|Net cash provided<br>by investing<br>activities|||||(1,130)||(689)|
|Increase/(Decrease)<br>in cash and cash equivalents|||||(1,489)||933|
|Cash and cash equivalents<br>at the start ofthe||year|||2,959||2,026|
|Cash and cash equivalents<br>at the end ofthe||year|||1,470||2,959|
|Reconciliation<br>ofnet income tonet cash flow from operating||||activities||||
|Net income/(expenditure)<br>forthe reporting||period (as per|||||PBS)|
|the Statement of Financial Activities)||||||||
|Adjustments<br>for:||||||||
|Dividends<br>and interest on investments|||||(198)||(103)|
|(Gains) / losses on investments|||||235||(252)|
|Depreciation|||||5||3|
|(Increase)/decrease<br>in stock|||||||(2)|
|(Increase)/decrease<br>in debtors|||||(321)||(348)|
|Increase/(decrease)<br>in creditors|||||(82)||3,109|
|Net cash provided/<br>(used in) by operating|activities||||(359)||1,622|
|Analysis ofcash and cash equivalents||||||||
|Bank current accounts|||||232||227|
|Bank deposit accounts|||||1,238||2,732|
|Total cash and cash equivalents|||||1,470||2,959|





## 

## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 

|harity|||||||
|---|---|---|---|---|---|---|
||||||Year ended 31|Year ended 31.|
||||||March 2023|March 2022|
||||||f'000|f'000|
|Gross incoming||resources|||7,936|6,287|
|Cost of raising funds|||||(1,524)|(1,376)|
|Cost ofcharitable|||activities||(6,175)|(5,948)|
|Net (outgoing)/||incoming resources|||237|(1,037)|
|Realised and unrealised||||gains / (losses) on|||
|investments|||||(235)|252|
|Total funds|brought forward||||7,748|8,533|
|Total funds|carried forward||||7,750|7,748|
|Represented<br>by:|||||||
|Restnicted|income||funds||3,476|3,054|
|Unrestricted|income funds||||4,274|4,694|
||||||7,750|7,748|
|ubsidiary|||||||
||||||Year ended 31|Year ended 31|
||||||March 2023|March 2022|
||||||f'000|f'OOO|
|Turnover|||||805|764|
|Operating costs|||||(349)|(346)|
|Operating|profit||||456|418|



## 

## 

|||Year|Ended||Year Ended|
|---|---|---|---|---|---|
||31|March|2023|31|March 2022|
||||fOOO||fOOO|
|Interest|||93||28|
|Dividends|||105||75|
|TOTAL|||198||103|





## 

## 

## 

|||Unrestricted|Restricted|Total Year|Unrestricted|Restricted|Total Year|
|---|---|---|---|---|---|---|---|
|||EOOD|EOOD|Ended 31|EOOD|EOOD|Ended 31|
|||||March 2023|||March 2022|
|||||EOOD|||EOOD|
|Donations and legacies:||||||||
|Donations<br>from individuals||513|775|1,288|867|513|1,380|
|Corporate donations||224|334|558|312|373|685|
|Danatians<br>from groups|Ik|145|45|190|50|9|59|
|associations||||||||
|Donations<br>in mernoriarn||102|45|147|82|46|128|
|Grant income||38|1,452|1,490|77|1,322|1,399|
|Legacies||1,270|121|1,391|543|1|544|
|Gifts in kind||393||393|197||197|
|Total danations<br>and legacies||2,685|2,772|5,457|2,128|2,264|4p392|
|Incame fram charitable||||||||
|activities:||||||||
|Fundraising<br>events||920|157|1,077|659|90|749|
|Lottery||760||760|667||667|
|Total income ham charitable||1,680|157|1,837|1,326|90|1,416|
|activities||||||||
|Income from other trading||||||||
|activities:||||||||
|Sale ofpromotional<br>items||792||792|722||722|
|Total income from other||792||792|722||722|
|trading activities||||||||



## 

## 

|||Year|Allocated to|Allocated|Year|Allocated to|Allocated|
|---|---|---|---|---|---|---|---|
|||Ended 31|Governance|to|Ended 31|Governance|to|
|||March 2023|K'000|Support|March 2022|000|sUpport|
|||Total||Casts|Total||costs|
|||E'000||E'000|E'ODO||E'000|
|Salaries||532|(138)|394|407|(128)|279|
|Bank and service charges||41||41|45|||
|Investment|management|42||42|36||36|
|costs||||||||
|Trust services||54||54|54||54|
|TOTAL||669|(138]|531|542|(128)|414|





## 

|Area ofExpenditure|Area ofExpenditure||Support||Investment|Total||
|---|---|---|---|---|---|---|---|
||||Charges<br>f'000|Governance<br>f'000|Management<br>f'000|f'000||
|Year Ended|31March 2023|||||||
|Patient Welfare|||489|138|42|669||
|Year Ended|31March 2022|||||||
|Patient Welfare|||378|128|36|542||
|||||||Year ended|Yearended|
|||||||31March|31March|
|Auditors'<br>Remuneration||||||2023|2022|
|||||||E.'000|f'000|
|Auditors'<br>remuneration||for||||10|10|
|audit||||||||
|Fees payable|to auditors|||||||
|for non-audit|services|||||||



## 

|.<br>Analysis of|Charitable<br>Expen|Charitable<br>Expen|diture||||||
|---|---|---|---|---|---|---|---|---|
||Grant Funding||Support|Total Year to|Grant Funding to||Support|Total Year to|
||to Alder Hey<br>Children's<br>NHS||Costs<br>f000|31March<br>2023|Alder Hey<br>Children's<br>NH5||Costs<br>f000|31March<br>2022|
||Foundation|||f000|Foundation|Trust||f000|
||Trust|f000||||f000|||
|Area of|||||||||
|expenditure:|||||||||
|Magic (Patient||1,996|669|2,665||1,696|542|2,238|
|welfare &Other)|||||||||
|Research &||1,279||1,279||370||370|
|innovation|||||||||
|Equipment||105||105||340||340|
|Campus &||2,125||2,125||3,000||3,000|
|Community|||||||||
|Total||5,505|669|6,174||5,406|542|5,948|





## 

## 

||Fundraising|Support|Governance|Total|
|---|---|---|---|---|
||&Publicity<br>f000|Costs<br>f000|f000|f000|
|Year Ended 31March 2023|||||
|Salades and Wages||331|119|1,234|
|Social Security Costs|69|29|15|113|
|Other Pension Costs|19|||32|
|Total Staff Costs|872|369|138|1,379|
|Average<br>Number of|||||
|Emp!oyees|26|||36|
|Year Ended 31March 2022|||||
|Salaries and Wages|585|251||947|
|Social Secudity Costs|54|21|13|88|
|Other Pension Costs|12|||22|
|Total Staff Costs|651|279|127|1,057|
|Average Number of|||||
|Employees|20|8|2|30|





## 

## 

|||2023|||2022||
|---|---|---|---|---|---|---|
|Group<br>Cast|Leasehald|improvements<br>f'000|Total<br>f'OM|Leasehald|Impravements<br>f'000|Total<br>f'000|
|At1April 2022||50|50||30|30|
|Additions|||||20|20|
|At31March 2023||50|50||50|50|
|Depreciation|||||||
|At 1April 2022|||||||
|Charge forthe year|||||||
|At 31March 2023||12|12||||
|Net BookValue|||||||
|At 31March 2023|||||||
|At 31March 2022||43|43||26|26|



## 

|||2023|2022|
|---|---|---|---|
|||f'OM|f'OM|
|Group||||
|Investment|porffo!io|9945|8852|
|Charity||||
|Investment|portfolio||8852|



||2023|2022|
|---|---|---|
||f'000|f'000|
|Market Value at 31March 2022|8,852|7,828|
|Additions atcost/deposits|3233|1,454|
|Disposals/withdrawals|i1,905)|(682)|
|itet (loss)/gain<br>on revaluation|i235)|252|
|Market Value carded forward|9,945|8,852|
|Historic cost at31March 2023|9,113|7,683|





## 

## 

## 

## 

|||||||Held|Held|Held|Total at|Held|Held|Held|Total at|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|||||||in UK|Outside|UK|31March|in UK|Outside|UK|31March|
|||||||f000|f000||2023|f000|f000||2022|
||||||||||EOOO||||f000|
|UK Equities||||||1,317|||1,317|1,443|||1,443|
|Overseas Equities|||||||1,666||1,666||1,873||1,873|
|Fixed|interest|||||772|||772|527||53|580|
|Cash|held|as|part|of|investment|S,255|||5,255|3,942|||3,942|
|portfolio||||||||||||||
|Alternatives||||||935|||935|1,014|||1,014|
|Total||||||8,279|1,666||9,945|6,926|1,926||8,852|



## 

## 

||||2023<br>E|2022f|
|---|---|---|---|---|
|issued share capital|||||
|Turnover<br>and other operating||income|805,382|764,387|
|Expenditure|||348,517|346,245|
|Total Assets|||606,810|468,854|
|Total Liabilities|||606,372|468,415|
|Shareholders'|Funds||438|439|





## 

## 

## 

||2023|2023|2022|2022|
|---|---|---|---|---|
||EOM|EOOO|f000|EOOO|
||Group|Charity|Group|Charity|
|Recoverable TaxBAccrued income|454|972|587|678|
|Other Debtors|488|146|34|171|
||942|1,118|621|849|
|There were no debtors falling due over one year.|||||



## 

## 

|ash h|eld by t|he G|roup / C|harity ca|n be summa<br>Ri|se d as:||||
|---|---|---|---|---|---|---|---|---|---|
|||||||2023|2023|2022|2022|
|||||||Group|Charity|Group|Charity|
|||||||EOM|f000|6000|6000|
|Bank|current|and|deposit|account|balances|1,470|L296|2,959|2,779|
|||||||1,470|1,296|2,959|2,779|



## 

|Falling due within one year:|2023|2023|2022|2022|
|---|---|---|---|---|
||Group|Charity|Group|Charity|
||6000|EOM|6000|EMO|
|Amount owed to subsidiary|||||
|Taxation and social security costs|77|27|21|21|
|Amount owed to Alder Key NHS Trust (recharged)|124|124|82|82|
|Amount owed to Alder Hey NHS Trust (accrued grant)|4,354|4,354|4,474|4,474|
|Pension contributions<br>due|9|9|12|12|
|Other creditors and accruals|117|95|174|143|
||4,681|4,609|4,763|4,732|





## 

## 

|Year ended 31March 2023:|Year ended 31March 2023:|Year ended 31March 2023:|Year ended 31March 2023:|Year ended 31March 2023:|||||
|---|---|---|---|---|---|---|---|---|
|Restricted Funds- Charity and Group|||||||||
|||||Balance|||||
|||||et|Incoming|Resources|Gains|Balance|
|||||1April|Resources|Expended|&|31March|
|||||2022|||Losses|2023|
|||||f000|f000|EOOO|f000|EOOO|
|Fund|||||||||
|John Lennon Research|||Fund|168||(12)||156|
|Neonatal|Capital|Fund||382|901|(978)||305|
|Projects Fund||||808|1,067|(350)||1,525|
|Alder Centre<br>Fund|||||10|(22)||47|
|Burns Unit Fund||||61||(5)||61|
|Leukaemia|Research Fund|||172||||177|
|Intensive|Care Fund|||121||(6)||117|
|Oncology|Fund|||166|34|(137)||63|
|Cancer Patients||Fund||71|117|||188|
|Neonatal|Fund|||81|63|(4)|||
|Neurology/|Neurodisabllity|||113|48|(50)|||
|Cardiac Surgery||Fund||178||||178|
|Others||||674|677|(943)||408|
|Total||||3,054|2,929|(2,507)||3,476|





## 

## 

## 

|Unrestri|cte|d<br>|Funds- Group|Funds- Group||||||
|---|---|---|---|---|---|---|---|---|---|
||||Balance at||incoming|Resources|Gains|Transfers|Balance|
||||31|March|Resources|Expended|&|f000|31March|
|||||2022|f000|f000|Losses||2023|
|||||f000|||EOOO||f000|
|Alder Hey||General||3,694|5,355|(4,540)|(235)||4,274|
|Purpose|Fund|||||||||
|Neonatal|Capital|||1,000||(1,000)||||
|Designated||Fund||||||||
|Total||||4,694|5,355|(9,540)|(235)||4&274|
|Unrestricted|||Funds - Charity|||||||
||||Balance at||Incoming|Resources|Gains &|Transfers|Balance|
||||31|March<br>2022|Resources<br>f000|Expended<br>f000|Losses<br>f000|f000|at 31<br>March|
|||||f000|||||2023|
||||||||||f000|
|Alder Hey||General||3,694|5,007|(4,192)|(235)||4,274|
|Purpose|Fund|||||||||
|Neonatal|Capital|||1,000||(1,000)||||
|Designated||Fund||||||||
|Total||||4,694|5,007|(5,192)|(235)||4,274|





## 

## 

## 

|Restricted Funds|- Ch|arity and|Group|||||
|---|---|---|---|---|---|---|---|
||||Balance at|Incoming|Resources|Gains|Balance at|
|Restricted<br>Funds|||31March<br>2021|Resources|Expensed|&<br>Lasses|31March<br>2022|
||||EOOO|EOOO|EOOO|6BOO|EOOO|
|Fund||||||||
|Iohn Lennon Research Fund|||168||||168|
|hieonata<br>I Capital|Fund|||382|||382|
|Projects Fund|||554|1,105|(851)||808|
|Alder Centre Fund|||57|52|(SO)||59|
|Burns Unit Fund|||61||(2)||61|
|Leukaemia<br>Research||Fund|172||||172|
|Oncology<br>Fund|||213|43|(90)||166|
|Intensive Care Fund|||119||(3)||121|
|Cancer Patients|Fund||70||||71|
|Hephrology<br>Fund|||97||(73)||24|
|Neonatal<br>Fund|||52|29|||81|
|Tier4Mental<br>Health|||250|547|(797)|||
|Cardiac Fund|||129|22|(133)||18|
|Cardiac Surgery|Fund||226||(50)||178|
|Others (55)|||731||(150)||745|
||||2,899|2,354|(2,199)||3,054|





## 

||||Balance at|Incoming|Resources|Gains 8c|Transfers|Balance at|
|---|---|---|---|---|---|---|---|---|
||||31March<br>2021|Resources<br>f000|Expended<br>f000|Losses<br>f000|f000|.March 2022<br>f000|
||||f000||||||
|Alder Hey||General Purpose|3,384|4,279|(3,268)|252|(953)|3,694|
|Fund|||||||||
|NeonatalCapital|||||||1,000|1,000|
|Designated||Fund|||||||
|Mental Health Designated|||2,250||(2,203)||(47)||
|Fund|||||||||
|Total|||5,634|4,279|(5,471)|252||4,694|
|nrestricted||Funds- Charity|||||||
||||Balance at|incoming|Resources|Gains Sa|Transfers|Balance at|
||||31March<br>2021|Resources<br>f000|Expended<br>f000|Losses<br>EOOD|f000|March 2022<br>f000|
||||f000||||||
|Alder Hey <br>Fund||General Purpose|3,384|3,933|(2,922)|252|(953)|3,694|
|Neonatal<br>Capital<br>Designated<br>Fund|||||||1,000|1,000|
|Mental<br>Health Designated<br>Fund|||2,250||(2,203)||(47)||
|Total|||5,634|3,933|(5,125)|252||4,694|



## 



## 

## 

## 

||Fixed|Current|Current|Long Term|Net|
|---|---|---|---|---|---|
|As at 31March 2023|Assets|Assets|Liabilities|Liabilities|Assets|
|||f000||||
|Charity:||||||
|Unrestricted|4,449|2,414|(2,589)||4,274|
|Restricted|5,496||[2,020)||3,476|
|Total|9,945|2,414|(4,609)||7,7SO|
|Group:||||||
|Unrestricted|4,487|2,448|(2,661)||4,274|
|Restricted|5,496||(2,020)||3,476|
|Total|9,983|2,448|(4,681)||7,750|
|Net assets (continued)||||||
||Fixed|Current|Current|Long Term|Net|
|As at31March 2022|Assets|Assets|Liabilities|Liabilities|Assets|
||f000|f000|||f000|
|Charity:||||||
|Unrestricted|4,076|3,628|(3,010)||4,694|
|Restricted|4,776||(1,722)||3,054|
|Total|8,852|3,628|(4,732)||7,748|
|Group:||||||
|Unrestricted|4,119|3,616|(3,041)||4,694|
|Restricted|4,776||(1,722)||3,054|
|Total|8,895|3,616|(4,763)||7,748|



## 

## 

## 



## 

## 

## 

## 

